RICHARD H. DOUGLAS, PH.D. - Corporate Board Profile

NOVAVAX INC

Filing Date	Source Excerpt
2011-04-29	Richard H. Douglas, Ph.D., Age 58, Senior Vice President Corporate Development, Genzyme Corporation. Director since 2010. Received $17,713 in fees and $31,404 in option awards for total compensation of $48,617 in 2010.
2012-04-30	Richard H. Douglas, Ph.D. received cash retainers of $25,000 as an outside director and $10,500 for his participation on the Audit, Compensation and Finance Committees. He received $12,500 for his attendance at Board and Committee meetings. Total compensation was $77,140.
2013-04-30	Richard H. Douglas, Ph.D. 60 Former Senior Vice President Corporate Development and a Corporate Officer of Genzyme Corporation. Dr. Douglas received cash retainers of $25,000 for his service as an outside director and $12,000 for his participation on the Audit, Compensation and Finance Committees. He received $7,000 for his attendance at Board meetings.
2014-04-30	Richard H. Douglas, Ph.D. 61 2010 Former Senior Vice President Corporate Development, Genzyme Corporation. From 1989 to 2011, Dr. Douglas led Genzyme Corporations Corporate Development team, and was involved in numerous acquisitions, licenses, financings, joint ventures, and strategic alliances.
2015-04-30	Richard H. Douglas, Ph.D. 62 2010 Former Senior Vice President Corporate Development, Genzyme Corporation. ... Dr. Douglas serves on the University of Michigan Technology Transfer National Advisory Board. ... The following table sets forth information concerning the compensation paid by the Company to each individual who served as a non-employee director at any time during fiscal year 2014: ... Richard H. Douglas, Ph.D. Fees Earned or Paid in Cash ($) 61,000 Option Awards ($) 119,415 Total ($) 180,415
2016-04-20	Richard H. Douglas, Ph.D. Age: 63 Former Senior Vice President, Corporate Development, Genzyme Corporation. Board Committees: Member of Audit Committee and Compensation Committee Summary Director Compensation Table: Richard H. Douglas, Ph.D. - Total compensation $317,800
2017-04-28	Richard H. Douglas, Ph.D. Age: 64 Year First Elected Director: 2010 Former Senior Vice President, Corporate Development, Genzyme Corporation. Dr. Douglas serves as a member of the boards of University of Michigan Technology Transfer National Advisory Board and Aldeyra Therapeutics, Inc. (ALDX).
2018-04-30	Richard H. Douglas, Ph.D. Age: 65 Year First Elected Director: 2010... Dr. Douglas serves as a member of the boards of University of Michigan Technology Transfer National Advisory Board, Aldeyra Therapeutics, Inc. (ALDX), and MaxCyte, Inc.... Board Committees: Audit Committee Member, Compensation Committee Member... Summary Director Compensation Table: Richard H. Douglas, Ph.D. Total: $233,512.
2019-04-01	Richard H. Douglas, Ph.D. is listed as a director in the Security Ownership table. No age, committees, or compensation details are provided.
2019-05-16	Richard H. Douglas, Ph.D. Former Senior Vice President, Corporate Development, Genzyme Corporation. From 1989 to 2011, Dr. Douglas led Genzyme Corporation’s Corporate Development team, and was involved in numerous acquisitions, licenses, financings, joint ventures, and strategic alliances. Board Committees Richard H. Douglas, Ph.D. Audit Committee Member Compensation Committee Member Summary Director Compensation Table Richard H. Douglas, Ph.D. Fees Earned or Paid in Cash: $57,375 Option Awards: $169,803 Total: $227,178
2020-05-13	Richard H. Douglas, Ph.D. Age: 67 Former Senior Vice President, Corporate Development, Genzyme Corporation Audit Committee Member Compensation Committee Member 2019 Compensation: $119,296
2021-05-03	Richard H. Douglas, Ph.D. Former Senior Vice President, Corporate Development, Genzyme Corporation Age 68 Director Since 2010 Committees: Audit, Compensation, Research and Development Compensation: $861,480 total compensation in 2020.
2022-05-02	Richard H. Douglas, Ph.D. Former Senior Vice President, Corporate Development, Genzyme Corporation Age 69 Director Since 2010 Committees: Audit, Compensation, Research and Development Compensation: $402,072
2023-04-28	Richard H. Douglas, Ph.D. Age 70 INDEPENDENT DIRECTOR SINCE 2010 COMMITTEES Audit Compensation Research & Development Fees Earned or Paid in Cash ($): 84,500 Option Awards ($): 172,134 Stock Awards ($): 125,922 Total ($): 382,556
2024-04-29	Richard H. Douglas, Ph.D. Independent Director since 2010 Committees: Audit, Compensation, Research & Development Director Compensation Table: Total compensation $189,533.